Johnson & Johnson
The Lead
NJ Jury Awards Woman $3.35 M in J&J Implant Suit
February 25, 2013 4:48 pm | by The Associated Press | News | Comments
A New Jersey jury has awarded $3.35 million to a former nurse who says Johnson & Johnson's vaginal mesh implant caused severe chronic pain despite 18 unsuccessful repair surgeries. It's the first verdict in about 4,000 lawsuits filed against the health products maker. At least one plaintiff...
Jury Adds $7.8M in J&J Punitive Damages
February 28, 2013 12:18 pm | by The Associated Press | News | Comments
A New Jersey jury has ordered Johnson & Johnson to pay punitive damages of $7.76 million to...
Jury Adds $7.8M in J&J Punitive Damages
February 28, 2013 12:18 pm | by The Associated Press | News | Comments
A New Jersey jury has ordered Johnson & Johnson to pay punitive damages of $7.76 million to...
NJ Jury Awards Woman $3.35 M in J&J Implant Suit
February 25, 2013 4:48 pm | by The Associated Press | News | Comments
A New Jersey jury has awarded $3.35 million to a former nurse who says Johnson & Johnson's...
FREE Daily Email Newsletter
J&J Anticipates 10 Potential New Product Filings by 2017
May 23, 2013 8:36 am | News | CommentsAt a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced they anticipate submitting more than 10 new product filings and more than 25 significant brand line extensions by 2017.
J&J's DePuy to End Two Hip Replacement Systems
May 17, 2013 12:05 pm | by The Associated Press | News | CommentsJohnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors. DePuy will discontinue both its Ultamet Metal-on-Metal Articulation and Complete Ceramic-on-Metal Acetabular systems worldwide at the end of August. It made the...
Shareholders Criticize J&J Management for Lapses
April 25, 2013 3:52 pm | by LINDA A. JOHNSON - AP Business Writer - Associated Press | News | CommentsSeveral Johnson & Johnson shareholders took the health care giant to task during its annual meeting, citing repeated product recalls, ethical lapses and excessive executive pay. CEO Alex Gorsky took it in stride, promising improvements and saying J&J is making progress in returning a...
J&J Q1 Profit Falls 10% Despite Higher Sales
April 16, 2013 8:21 am | by The Associated Press | News | CommentsJohnson & Johnson says its first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and administration. The maker of Tylenol, prescription drugs and medical devices says it earned $3.5 billion, or $1.22 per share, down 10.6 percent from $3.9 billion, or $1.41 per share, a year earlier.
Johnson & Johnson Reports 2013 First-Quarter Results
April 16, 2013 7:52 am | News | CommentsJohnson & Johnson today announced sales of $17.5 billion for the first quarter of 2013, an increase of 8.5% as compared to the first quarter of 2012. Operational results increased 9.8% and the negative impact of currency was 1.3%. Domestic sales increased 11.2 %. International sales increased 6.3%, reflecting operational growth of 8.7% and a negative currency impact of 2.4%.
Heir to Johnson & Johnson Wealth Buried in Poland
April 15, 2013 11:14 am | News | CommentsBarbara Piasecka Johnson, a former maid who married the American heir to the Johnson & Johnson fortune, was buried Monday in her home town in Poland after a modest funeral attended by about 200 people. An art collector and philanthropist, Piasecka Johnson died at age of 76 on April 1 near Wroclaw, in southwestern Poland. She lived and studied art history in Wroclaw before moving to the United States in 1968.
Earnings Preview: J&J 1Q to Focus on Newest Drugs
April 12, 2013 11:28 am | by LINDA A. JOHNSON,AP Business Writer | News | CommentsJohnson & Johnson will highlight the recent approval of its first drug in the huge diabetes market, plus progress toward getting two other drugs approved, when it announces first-quarter results before the stock market opens Tuesday.
Johnson & Johnson Shares Dip on Analyst Downgrade
April 9, 2013 8:06 am | by LINDA A. JOHNSON,AP Business Writer | News | CommentsShares of Johnson & Johnson fell Monday after a J.P. Morgan analyst downgraded the health care giant's stock, saying it now trades at an 8 percent premium to the value of its parts and he expects the company to reduce its profit forecast.
Court Overturns $482M Patent Decision Against J&J
April 4, 2013 3:09 pm | by The Associated Press | News | CommentsA federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company. The three-judge panel said a lower court misinterpreted the company's patent and should not have ruled in favor...
Heir to Johnson & Johnson Fortune Dies at 76
April 4, 2013 7:50 am | by VANESSA GERA,Associated Press | News | CommentsBarbara Piasecka Johnson, a Polish farmer's daughter who worked as a maid for an American heir to the Johnson & Johnson fortune before marrying him and eventually inheriting much of his wealth, has died at the age of 76. Johnson, the widow of J. Seward Johnson Sr., became embroiled in a nasty and prominent legal battle when her husband died in 1983.
CVS Caremark Adds Former J&J CEO Weldon to Board
April 1, 2013 1:36 pm | by The Associated Press | News | CommentsDrugstore operator CVS Caremark Corp.'s board of directors has elected former Johnson & Johnson Chairman and CEO William C. Weldon to join the board. The Woonsocket, R.I., company late Friday said that Weldon's experience in managing a complex health care company and his knowledge of the...
FDA OKs First-of-its-Kind Diabetes Drug
March 29, 2013 4:02 pm | by The Associated Press | News | CommentsThe U.S. Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine. The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes. The once-a-day...
J&J Recalls All OneTouch Verio Blood Sugar Meters
March 25, 2013 11:28 am | by The Associated Press | News | CommentsJohnson & Johnson has announced a voluntary recall for all its OneTouch VerioIQ blood glucose meters in the U.S. because they do not provide a warning when a diabetic's blood sugar level is dangerously high. Instead, the meters turn off. The meters are made by J&J's LifeScan unit, which...
J&J: No One in SC Was Harmed in $327M Case
March 21, 2013 1:46 pm | by MEG KINNARD - Associated Press - Associated Press | News | CommentsA Johnson & Johnson subsidiary says South Carolina's high court should overturn a multi-million-dollar penalty over deceptive drug marketing, in part because no one in the state was hurt. Attorney Mitch Brown told the state Supreme Court on Thursday that Janssen Pharmaceutica Inc. should not...
SC Court Hearing Appeal of $327M Drug Lawsuit
March 21, 2013 4:01 am | by MEG KINNARD - Associated Press - Associated Press | News | CommentsA Johnson & Johnson subsidiary says South Carolina's high court should overturn a decision fining the company hundreds of millions of dollars over deceptive drug marketing. The state Supreme Court on Thursday is hearing an appeal from attorneys for Janssen Pharmaceutica Inc. The drug maker is...
SC Court to Hear Janssen Pharmaceutica Appeal over $327M Award
March 18, 2013 1:08 pm | by MEG KINNARD - Associated Press - Associated Press | News | CommentsA Johnson & Johnson subsidiary is going to South Carolina's Supreme Court later this week to argue why it shouldn't have to pay the state hundreds of millions of dollars for deceptive drug marketing. On Thursday, attorneys for Janssen Pharmaceutica Inc. — a subsidiary of the New Brunswick,...
J&J Lowers Exec Bonuses, Citing 'Disappointments'
March 13, 2013 6:22 pm | by LINDA A. JOHNSON - AP Business Writer - Associated Press | News | CommentsJohnson & Johnson has lowered planned bonuses by 10 percent for new CEO Alex Gorsky and other top executives. The giant health products maker cited a "mix of short-term successes and disappointments" last year, including its failure to get many of its recalled nonprescription medicines back...
Johnson & Johnson Announces Opening of London Innovation Centre
March 13, 2013 7:58 am | News | CommentsJohnson & Johnson today announced the opening of the Johnson & Johnson Innovation centre in London, one of four regional hubs being established this year in the world's leading innovation hotspots. A part of Johnson & Johnson Innovation, the goal of the London innovation centre is to accelerate the best early stage science in the world and advance the development of new healthcare solutions.
Drugmakers, Interpol Ramp Up Fight Against Fakes
March 12, 2013 1:01 am | by LINDA A. JOHNSON - AP Business Writer - Associated Press | News | CommentsMore than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said Tuesday. Interpol's newly created Pharmaceutical Crime Program aims to help health...
J&J says FDA Denies New Xarelto Application
March 5, 2013 10:33 am | by The Associated Press | News | CommentsJohnson & Johnson said Monday that regulators have again refused to grant a new marketing approval to its anticlotting drug Xarelto. The company has asked the Food and Drug Administration to approve Xarelto for reducing the risk of heart attack and other cardiovascular problems in patients...
Feds Probe J&J on Recalled Hip Implant Marketing
February 22, 2013 12:43 pm | by The Associated Press | News | CommentsHealth care giant Johnson & Johnson says it's under investigation by federal prosecutors over the company's practices in marketing a line of hip replacements recalled two years ago because many failed and had to be replaced within five years. The U.S. Attorney's Office in Massachusetts and...
J&J Again Recalls Thousands of Faulty Hip Implants
February 14, 2013 1:54 pm | by LINDA A. JOHNSON,AP Business Writer | News | CommentsJohnson & Johnson has again recalled thousands of its hip implants, 2 1/2 years after the problem-plagued health care giant issued a recall of two other types of its artificial hips. Spokeswomen for J&J's DePuy Orthopaedics unit said Thursday that the company recalled the "Adept" brand all-metal total hip replacement system starting last month because a higher-than-expected percentage of them had to be replaced.
Massachusetts Girl, Parents Awarded $63M in Motrin Lawsuit
February 13, 2013 4:04 pm | by The Associated Press | News | CommentsHealth care company Johnson & Johnson has been told to pay a Massachusetts teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago. A Plymouth Superior Court jury Wednesday...
Greek Prosecutors Bring Charges Over DePuy Deals
February 12, 2013 2:49 pm | by The Associated Press | News | CommentsGreek prosecutors have brought criminal corruption charges related to state hospital purchases from DePuy, a subsidiary of U.S. healthcare giant Johnson & Johnson. Court officials said Tuesday that five DePuy officials have been charged with bribery and money laundering over deals between...
Arkansas Judge Affirms J&J Must Pay $181M in Legal Fees
February 1, 2013 8:34 am | News | CommentsA Pulaski County judge says Johnson & Johnson must pay $181 million in legal fees to attorneys who successfully argued that the pharmaceutical company committed Medicaid fraud over the marketing of its antipsychotic drug Risperdal. Judge Tim Fox ruled Thursday that Arkansas taxpayers should not foot the bill in the lawsuit filed by the state's attorney general.
